1. Tang J.，et al.Propofol lowers serum PF4 level and partially corrects hypercoagulopathy in endotoxemic rats.Biochim Biophys Acta，2010，1804（9）：1895-1901.

2. Tang J.，et al.Propofol inhibits the activation of p38 through up-regulating the expression of annexin A1 to exert its antiinflammation effect.PLoS One，2011，6（12）：e27890.

3. Liu J.et al.Advanced glycation end products and lipopolysaccharide synergistically stimulate proinflammatory cytokine/ chemokine production in endothelial cells via activation of both mitogen-activated protein kinases and nuclear factorkappaB.Febs j，2009，276（16）：4598-4606.

4. Bennett-Guerrero E.，et al.Decreased endotoxin immunity is associated with greater mortality and/or prolonged hospitalization after surgery.Anesthesiology，2001，94（6）：992-998.

5. Tang J.，et al.Role of HMGB1 in propofol protection of rat intestinal epithelial cells injured by heat shock.Cell Biol Int，2013，37（3）：262-266.

6. Chen X.C.，et al.Epidemiology and microbiology of sepsis in mainland China in the first decade of the 21 century.Int J Infect Dis，2014.

7. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell，2000，103（2）：211-225.

8. Wang C.，X.Guo，R.Xi.EGFR and Notch signaling respectively regulate proliferative activity and multiple cell lineage differentiation of Drosophila gastric stem cells. Cell Res，2014，24（5）：610-627.

9. Haskins J.W.，D.X.Nguyen，D.F.Stern.Neuregulin 1-activated ERBB4 interacts with YAP to induce Hippo pathway target genes and promote cell migration. Sci Signal，2014，7 （355）：ra116.

10. Wells，A.EGF receptor.Int J Biochem Cell Biol，1999，31 （6）：637-643.

11. Frey M.R.，D.Brent Polk.ErbB receptors and their growth factor ligands in pediatric intestinal inflammation. Pediatr Res，2014，75（1-2）：127-132.

12. Brennan P.J.，et al.HER2/Neu：mechanisms of dimerization/oligomerization.Oncogene，2002，21（2）：328.

13. Zhang X.，et al.Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface. Nature，2007，450（7170）：741-744.

14. Zhang X.，et al.An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. Cell，2006，125（6）：1137-1149.

15. Qiu C.，et al.Mechanism of activation and inhibition of the HER4/ErbB4 kinase.Structure，2008，16（3）：460-7.

16. Lenferink A.E.，et al.Differential endocytic routing of homoand hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers. EMBO J，1998，17 （12）：3385-3397.

17. Cohen B.D.，et al.The relationship between human epidermal growth-like factor receptor expression and cellular transformation in NIH3T3 cells. J Biol Chem，1996，271 （48）：30897-30903.

18. Cushing L.，et al.Interleukin 1/Toll-like receptor-induced autophosphorylation activates interleukin 1 receptor-associated kinase 4 and controls cytokine induction in a cell typespecific manner. J Biol Chem，2014，289（15）：10865-10875.

19. Inoue M.，et al.T cells down-regulate macrophage TNF production by IRAK1-mediated IL-10 expression and control innate hyperinflammation.Proc Natl Acad Sci U S A，2014，111（14）：5295-5300.

20. Kuper C.，F.X.Beck，W.Neuhofer.Toll-like receptor 4 activates NF-kappaB and MAP kinase pathways to regulate expression of proinflammatory COX-2 in renal medullary collecting duct cells.Am J Physiol Renal Physiol，2012，302 （1）：F38-46.

21. Tse K.H.，et al.Lipopolysaccharide differentially modulates expression of cytokines and cyclooxygenases in dorsal root ganglion cells via Toll-like receptor-4 dependent pathways. Neuroscience，2014，267：241-51.

22. Zhao H.，et al.Hypertonic induction of COX-2 expression in renal medullary epithelial cells requires transactivation of the EGFR. Am J Physiol Renal Physiol，2003，285（2）：F281-288.

23. Koff J.L.，et al.Multiple TLRs activate EGFR via a signaling cascade to produce innate immune responses in airway epithelium.Am J Physiol Lung Cell Mol Physiol，2008，294 （6）：L1068-1075.

24. Bergin D.A.，et al.Activation of the epidermal growth factor receptor（EGFR）by a novel metalloprotease pathway.J Biol Chem，2008，283（46）：31736-31744.

25. Jijon H.B.，et al.The EGF receptor and HER2 participate in TNF-αlpha-dependent MAPK activation and IL-8 secretion in intestinal epithelial cells. Mediators Inflamm，2012，2012：207398.

26. McElroy S. J.，et al. Transactivation of EGFR by LPS induces COX-2 expression in enterocytes.PLoS One，2012，7 （5）：e38373.

27. Okayasu K.，et al.RANTES expression induced by Toll-like receptor 4 ligand in rat airway smooth muscle cells.J Med Dent Sci，2010，57（4）：193-201.

28. Yu H.，et al.Regulation of cigarette smoke-mediated mucin expression by hypoxia-inducible factor-1alpha via epidermal growth factor receptor-mediated signaling pathways.J Appl Toxicol，2012，32（4）：282-292.

29. Binker M.G.，et al.LPS-stimulated MUC5AC production involves Rac1-dependent MMP-9 secretion and activation in NCI-H292 cells.Biochem Biophys Res Commun，2009，386 （1）：124-129.

30. Buontempo F.，et al.Activity of the selective IkappaB kinase inhibitor BMS-345541 against T-cell acute lymphoblastic leukemia：involvement of FOXO3a. Cell Cycle，2012，11 （13）：2467-2475.

31. Shimizu K.，et al.Hepatocyte growth factor inhibits lipopolysaccharide-induced oxidative stress via epithelial growth factor receptor degradation.Arterioscler Thromb Vasc Biol，2012，32（11）：2687-2693.

32. Hsu D.，et al.Toll-like receptor 4 differentially regulates epidermal growth factor-related growth factors in response to intestinal mucosal injury.Lab Invest，2010，90（9）：1295-1305.

33. Park C.M.，et al.Luteolin and chicoric acid synergistically inhibited inflammatory responses via inactivation of PI3KAkt pathway and impairment of NF-kappaB translocation in LPS stimulated RAW 264.7 cells.Eur J Pharmacol，2011，660（2-3）：454-459.